Familial hypercholesterolemia is
The core concept here is probably the inheritance pattern and the pathophysiology. The question is asking what FH is, so the options might include different inheritance types or pathophysiological mechanisms. The correct answer should be autosomal dominant.
Why is autosomal dominant correct? Because FH is caused by mutations in the LDL receptor gene (LDLR), which is on chromosome 19. This leads to reduced clearance of LDL from the blood, causing high cholesterol levels. Homozygous individuals have severe hypercholesterolemia, but the inheritance is dominant because even one copy of the mutated gene is enough to impair LDL receptor function.
Now, the wrong options: If the options include autosomal recessive, that's incorrect because FH is dominant. If there's a statement about high HDL, that's wrong because FH is about LDL. Also, options about other lipoproteins like VLDL might not be the primary issue here. Another wrong option might be about a different inheritance pattern, like X-linked, which isn't the case for FH.
Clinical pearls: Remember that FH is autosomal dominant, caused by LDLR mutations, leading to high LDL and atherosclerosis risk. Early screening and treatment are crucial for patients with FH.
**Core Concept**
Familial hypercholesterolemia (FH) is an **autosomal dominant** disorder caused by mutations in the **LDL receptor (LDLR)** gene, impairing hepatic LDL clearance and leading to severe hypercholesterolemia. It is a major risk factor for premature atherosclerotic cardiovascular disease.
**Why the Correct Answer is Right**
FH results from **heterozygous mutations** in the **LDLR gene**, reducing low-density lipoprotein (LDL) receptor activity. This impairs hepatic uptake of LDL from the bloodstream, causing **elevated plasma LDL-C levels**. The autosomal dominant inheritance means a single defective allele is sufficient to disrupt LDL metabolism, even in the presence of a functional allele. Homozygous FH (rare) involves two defective alleles and presents with extreme hypercholesterolemia and early-onset coronary artery disease.
**Why Each Wrong Option is Incorrect**
**Option A:** *Autosomal recessive* β FH is **autosomal dominant**, not recessive. Recessive disorders require two defective alleles, which is not the case here.
**Option B:** *X-linked inheritance* β FH mutations are on **chromosome 19**, making it **autosomal**, not X-linked.
**Option C:** *Defect in HDL receptor* β FH specifically involves **LDL receptor** dysfunction, not HDL receptors.
**Option D:** *Increased hepatic VLDL production* β FH does not involve increased VLDL synthesis; the defect is in **LDL clearance**, not production.
**Clinical Pearl / High-Yield Fact**
FH is diagnosed clinically using criteria like **Dutch Lipid Clinic Network (DLCN)** scores or **Framingham criteria**. Genetic testing confirms mutations in **LDLR, A